Tyrosine Kinase 2 Inhibitor

All categories
Name
Tyrosine Kinase 2 Inhibitor
Accession Number
DBCAT005872
Description

Not Available

Drugs
DrugDrug Description
DeucravacitinibA TYK2 inhibitor being investigated as a treatment for psoriasis.
Drugs & Drug Targets
DrugTargetType
DeucravacitinibNon-receptor tyrosine-protein kinase TYK2target
DeucravacitinibCytochrome P450 1A2enzyme
DeucravacitinibCytochrome P450 2B6enzyme
DeucravacitinibCytochrome P450 2D6enzyme
DeucravacitinibCocaine esteraseenzyme
DeucravacitinibUDP-glucuronosyltransferase 1-9enzyme
DeucravacitinibP-glycoprotein 1transporter
DeucravacitinibATP-binding cassette sub-family G member 2transporter
DeucravacitinibSolute carrier family 22 member 1transporter
DeucravacitinibSolute carrier organic anion transporter family member 1B3transporter